Short Interest in Vycor Medical, Inc. (OTCMKTS:VYCO) Rises By ∞

Vycor Medical, Inc. (OTCMKTS:VYCO – Get Free Report) was the target of a large growth in short interest in April. As of April 30th, there was short interest totaling 11,339 shares, a growth of ∞ from the April 15th total of 0 shares. Based on an average daily volume of 13,309 shares, the days-to-cover ratio is currently 0.9 days. Approximately 0.0% of the company’s stock are sold short.

Vycor Medical Stock Performance

Vycor Medical stock opened at $0.07 on Monday. The company has a fifty day simple moving average of $0.08 and a 200-day simple moving average of $0.12. The stock has a market cap of $2.34 million, a P/E ratio of -6.99 and a beta of -0.53. Vycor Medical has a 12-month low of $0.03 and a 12-month high of $0.20.

Vycor Medical Company Profile

(Get Free Report)

Vycor Medical, Inc is a medical device company specializing in the design, development and manufacture of minimally invasive cranial access systems for use in neurosurgery. The company’s proprietary endoport platform is engineered to provide neurosurgeons with controlled, cannula-based access for intracranial procedures such as tumor biopsy, resection and hematoma drainage. By integrating visualization channels and atraumatic retraction technology, Vycor’s products are intended to reduce collateral damage to healthy brain tissue and streamline procedural workflows.

The company’s core portfolio includes its flagship endoport system along with complementary accessories such as obturators, sheaths and closure devices.

Further Reading

• Five stocks we like better than Vycor Medical
• These Stocks Could Be the Biggest Winners of the 2026 Midterms
• 3 Infrastructure Stocks Fueling the Data Center Building Boom
• Datadog Soars, Dynatrace Slumps: Gap Widens in AI Agent Stocks
• As U.S. Debt Surpasses GDP, These 2 ETFs Are Emerging Winners in the “Sell America” Trade

Receive News & Ratings for Vycor Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vycor Medical and related companies with MarketBeat.com's FREE daily email newsletter.